Gufic Biosciences Investor Relations Material
Latest events
Q4 24/25
Gufic Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Gufic Biosciences Limited
Access all reports
Gufic Biosciences Limited is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical formulations, active pharmaceutical ingredients (APIs), and herbal products. The company specializes in injectables, lyophilized formulations, antifungals, antibiotics, and critical care medicines, catering to both domestic and international markets. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Key slides for Gufic Biosciences Limited
Q4 24/25
Gufic Biosciences Limited
Q3 24/25
Gufic Biosciences Limited
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
509079
Country
🇮🇳 India